Explore this recorded session from the American Diabetes Association’s 2026 Scientific Sessions reviewing major advances in obesity care, including emerging medications, treatment maintenance, and strategies to balance weight loss with side effects and lean-mass changes. The talks also examine preclinical insights into drug action and obesity physiology, followed by a discussion of clinical guidance, personalized treatment, and future research priorities.